Biopharmaceutical contract manufacturer Sigma-Tau PharmaSource has entered into a manufacturing services agreement with Aradigm, a specialty pharmaceutical firm focused on the development and commercialization of drugs delivered by ...
The US Food and Drug Administration (FDA) has cleared Sigma-Tau Pharmaceuticals' topical ophthalmic therapeutic to treat corneal cystine crystals in cystinosis patients. The CYSTARAN 0.44% solution, which is developed in collaboration ...